Sentynl Therapeutics Recognizes Menkes Disease Awareness Month, Committed to the Development of Tests for Early Diagnosis of Patients with Menkes Disease

/PRNewswire/ -- Sentynl Therapeutics, Inc. ("Sentynl") a US-based biopharmaceutical company focused on bringing innovative therapies to patients living with...

Related Keywords

California ,United States ,Jamie Eckman ,Michael Hercz ,Founders Of The Menkes Foundation ,Menkes Foundation ,Sentynl Therapeutics Inc ,Zydus Group ,Newborn Screening Program ,Rady Children Institute For Genomic Medicine ,Prnewswire Sentynl Therapeutics Inc ,Menkes Disease Awareness ,Matt Heck ,Chief Executive ,Rady Children ,Genomic Medicine ,Sentynl Therapeutics ,Genome Aggregation Database ,Molecular Genetics ,Metabolism Reports ,Occipital Horn Syndrome ,Distal Motor ,